lvv-hemorphin-7 has been researched along with diazepam in 1 studies
| Studies (lvv-hemorphin-7) | Trials (lvv-hemorphin-7) | Recent Studies (post-2010) (lvv-hemorphin-7) | Studies (diazepam) | Trials (diazepam) | Recent Studies (post-2010) (diazepam) |
|---|---|---|---|---|---|
| 59 | 0 | 14 | 18,377 | 2,329 | 1,790 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Camargo-Silva, G; Costa, EA; da Cruz, KR; Galdino, P; Ghedini, PC; Gomes, KP; Ianzer, D; Mendonça, MM; Rodrigues-Silva, C; Santos, RAS; Turones, LC; Xavier, CH | 1 |
1 other study(ies) available for lvv-hemorphin-7 and diazepam
| Article | Year |
|---|---|
The hemoglobin derived peptide LVV-hemorphin-7 evokes behavioral effects mediated by oxytocin receptors.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Behavior, Animal; Depression; Diazepam; Hemoglobins; Hormone Antagonists; Imipramine; Male; Motor Activity; Peptide Fragments; Rats; Rats, Wistar; Receptors, Oxytocin; Vasotocin | 2017 |